Literature DB >> 32562618

PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.

Simote T Foliaki1, Victoria Lewis1, Abu M T Islam1, Matteo Senesi1, David I Finkelstein2, Laura J Ellett3, Victoria A Lawson3, Paul A Adlard2, Blaine R Roberts2, Steven J Collins4.   

Abstract

Prion diseases are neurodegenerative disorders pathogenically linked to cellular prion protein (PrPC) misfolding into abnormal conformers (PrPSc), with PrPSc underpinning both transmission and synaptotoxicity. Although the biophysical features of PrPSc required to induce acute synaptic dysfunction remain incompletely defined, we recently reported that acutely synaptotoxic PrPSc appeared to be oligomeric. We herein provide further insights into the kinetic and requisite biophysical characteristics of acutely synaptotoxic ex vivo PrPSc derived from the brains of mice dying from M1000 prion disease. Pooled fractions of M1000 PrPSc located within the molecular weight range approximating monomeric PrP (mM1000) generated through size exclusion chromatography were found to harbor acute synaptotoxicity equivalent to preformed oligomeric fractions (oM1000). Subsequent investigation showed mM1000 corresponded to PrPSc rapidly concatenating in physiological buffer to exist as predominantly, closely associated, small oligomers. The oligomerization of PrP in mM1000 could be substantially mitigated by treatment with the antiaggregation compound epigallocatechin gallate, thereby maintaining the PrPSc as primarily nonoligomeric with completely abrogated acute synaptotoxicity; moreover, despite epigallocatechin gallate treatment, pooled oM1000 remained oligomeric and acutely synaptotoxic. A similar tendency to rapid formation of oligomers was observed for PrPC when monomeric fractions derived from size exclusion chromatography of normal brain homogenates (mNBH) were pooled, but neither mNBH nor preformed higher-order NBH complexes (oNBH) were acutely synaptotoxic. Oligomers formed from mNBH could be reduced to mainly monomers (<100 kDa) after enzymatic digestion of nucleic acids, whereas higher-order PrP assemblies derived from pooled mM1000, oM1000, and oNBH resisted such treatment. Collectively, these findings support that oligomerization of PrPSc into small multimeric assemblies appears to be a critical biophysical feature for engendering inherent acute synaptotoxicity, with preformed oligomers found in oM1000 appearing to be stable, tightly self-associated ensembles that coexist in dynamic equilibrium with mM1000, with the latter appearing capable of rapid aggregation, albeit initially forming smaller, weakly self-associated, acutely synaptotoxic oligomers.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32562618      PMCID: PMC7335956          DOI: 10.1016/j.bpj.2020.04.040

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  44 in total

1.  Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Authors:  Marcus W Brazier; Victoria Lewis; Giuseppe D Ciccotosto; Genevieve M Klug; Victoria A Lawson; Roberto Cappai; James W Ironside; Colin L Masters; Andrew F Hill; Anthony R White; Steven Collins
Journal:  Brain Res Bull       Date:  2005-10-05       Impact factor: 4.077

2.  Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells.

Authors:  Saima Zafar; Nicolas von Ahsen; Michael Oellerich; Inga Zerr; Walter J Schulz-Schaeffer; Victor W Armstrong; Abdul R Asif
Journal:  J Proteome Res       Date:  2011-06-07       Impact factor: 4.466

3.  Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Authors:  Charles E Mays; Jacques van der Merwe; Chae Kim; Tracy Haldiman; Debbie McKenzie; Jiri G Safar; David Westaway
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

4.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Authors:  Darragh B Freir; Andrew J Nicoll; Igor Klyubin; Silvia Panico; Jessica M Mc Donald; Emmanuel Risse; Emmanuel A Asante; Mark A Farrow; Richard B Sessions; Helen R Saibil; Anthony R Clarke; Michael J Rowan; Dominic M Walsh; John Collinge
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

5.  Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.

Authors:  Angelika S Rambold; Margit Miesbauer; Diana Olschewski; Ralf Seidel; Constanze Riemer; Lindsay Smale; Lisa Brumm; Michal Levy; Ehud Gazit; Dieter Oesterhelt; Michael Baier; Christian F W Becker; Martin Engelhard; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Neurochem       Date:  2008-08-07       Impact factor: 5.372

Review 6.  Prion protein oligomer and its neurotoxicity.

Authors:  Pei Huang; Fulin Lian; Yi Wen; Chenyun Guo; Donghai Lin
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-04-04       Impact factor: 3.848

7.  Disease-associated prion protein oligomers inhibit the 26S proteasome.

Authors:  Mark Kristiansen; Pelagia Deriziotis; Derek E Dimcheff; Graham S Jackson; Huib Ovaa; Heike Naumann; Anthony R Clarke; Fijs W B van Leeuwen; Victoria Menéndez-Benito; Nico P Dantuma; John L Portis; John Collinge; Sarah J Tabrizi
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

8.  Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.

Authors:  Victoria Lewis; Cathryn L Haigh; Colin L Masters; Andrew F Hill; Victoria A Lawson; Steven J Collins
Journal:  Mol Neurodegener       Date:  2012-04-26       Impact factor: 14.195

Review 9.  Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.

Authors:  Shichun Tu; Shu-ichi Okamoto; Stuart A Lipton; Huaxi Xu
Journal:  Mol Neurodegener       Date:  2014-11-14       Impact factor: 14.195

10.  Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

Authors:  Giovanna Mallucci; Andrew Dickinson; Jacqueline Linehan; Peter-Christian Klöhn; Sebastian Brandner; John Collinge
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.